Pricing Log in Create free account

Korro Bio, Inc. (KRRO) vs Sol-Gel Technologies Ltd. (SLGL)

Korro Bio, Inc. and Sol-Gel Technologies Ltd. are both Biotechnology companies. Korro Bio, Inc. and Sol-Gel Technologies Ltd. are of similar size ($202.5M and $199.8M). Korro Bio, Inc. grew revenue faster over the last twelve months: −81.9% against −92.5%. Korro Bio, Inc. has the higher net margin (0.00% vs −910.1%) and the higher return on invested capital (0.00% vs −6,630.2%). Across the 15 metrics below, Korro Bio, Inc. leads on 9 and Sol-Gel Technologies Ltd. on 6.

Valuation

Metric KRRO SLGL Biotechnology median
P/E n/m n/m 10.60
P/S 40.65 111.18 9.40
P/B 2.52 4.15 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 25.53 120.87 9.02
Earnings yield (67.80%) (9.24%) (32.88%)
Free cash flow yield (26.27%) (10.66%) (23.13%)

Profitability

Metric KRRO SLGL Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (986.96%) 0.00%
Net margin 0.00% (910.14%) 0.00%
Free cash flow margin 0.00% (1,185.18%) 0.00%
Return on equity (97.69%) (40.85%) (51.96%)
Return on assets (62.03%) (35.11%) (46.06%)
Return on invested capital 0.00% (6,630.24%) 0.00%

Growth

Metric KRRO SLGL Biotechnology median
Revenue growth (TTM) (81.87%) (92.50%) 6.76%
EPS growth (last fiscal year) (33.19%) 42.37% 29.88%
Revenue growth, 5-year CAGR — 17.19% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO SLGL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.55 10.37 4.97
Net debt to EBITDA 0.64 3.23 1.01

Dividend

Metric KRRO SLGL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KRRO SLGL Biotechnology median
Market cap 202.45m 199.75m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack